undamentalytics Newsletter
Sign in

Enovis Corp cash flow statement

In fiscal 2025, Enovis Corp's operations generated $217m of cash; it spent $197m on capital projects, leaving free cash flow of $19.9m. It returned $3.5m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJul 2026
Cash from operations396257174362386304247219226131302356−56135114217270
Depreciation and amortisation—172318311917513712973812161681872032179281,3441,346
Stock-based pay33591318161922252229353934303335
Capital spending11131584718470636970125115104105122181197206
Free cash flow284942902913012341841501576187252−16113−672064
Free cash flow after stock pay25463781277284218165128132−16158217−200−21−97−1329
Dividends paid—000——————————————
Share buybacks————002721020000—0054—
Shares issued—14757324614627512474562211

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ENOV vs TFXENOV vs QDELENOV vs ITGR

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Enovis Corp's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Enovis Corp.